Harrow Stock (NASDAQ: HROW) stock price, news, charts, stock research, profile.
You can purchase shares of Harrow (NASDAQ:HROW) through any online brokerage.
Other companies in Harrow’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).
Harrow has a consensus price target of $44.33.
The stock price for Harrow (NASDAQ: HROW) is $50.64 last updated October 7, 2024 at 4:36 PM EDT.
There are no upcoming dividends for Harrow.
Harrow’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Harrow.
Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.